NeuroPharmac Journal
Latest Publications


TOTAL DOCUMENTS

47
(FIVE YEARS 31)

H-INDEX

1
(FIVE YEARS 1)

Published By Neuropharmac Journal

2456-3927

2021 ◽  
pp. 241-247
Author(s):  
Medhat Farag ◽  
Aslam Pathan ◽  
Nawaf Aldoaij

The global health pandemic of coronavirus disease (Covid-19) did not have specifically approved medication for the treatment. To maintain the human immunity power by natural remedies is the only way to prevent coronavirus infection. We designed a study protocol by selecting 10 natural plant active constituents that were claimed by traditional and investigational ways to have anti-inflammatory, antioxidant, immunomodulatory, and antiviral properties. We will analyze these selected 10 plants' active constituents by molecular docking analysis. This article is a literature review of selected 10 plants products including Coffea Arabica, Curcuma longa, Glycyrrhiza glabra, Zizyphus vulgaris, Sisymbrium irio, Borago officinalis, Althaea officinalis, Malva sylvestris, Cordia Latifolia, and Adhatoda vasica for their anti-inflammatory, antioxidant, immunomodulatory, and antiviral properties.


2021 ◽  
pp. 295-310
Author(s):  
Iqra Khan ◽  
Salman Akhtar ◽  
Mohammad Kalim Ahmad Khan

With the transforming world, awareness of lifestyle-based variation is necessary. The availability of the locally available network and smart devices like wearable health devices (WHDs) based on artificial intelligence (AI) technology prompted us to learn about the disease, its causes, spreads, and precautions. Socioeconomic, environmental and behavioural factors, international travel and migration foster and increase the spread of communicable diseases. Vaccine-preventable, foodborne, zoonotic, healthcare-related and communicable diseases pose significant threats to human health and may sometimes threaten international health security. On the other hand, non-communicable diseases, also known as chronic diseases, are more prolonged. It could be the cause of different factors like genetic, environmental, behavioural or physiological disturbances. Smart wearables help to keep these diseases in check through different sensors installed in them. They can check for the difference in body function, but they can also help the needy consult the physician or practitioner. The data collected from these devices can also check the current health status when compiled with data collected practically. Organizations viz., World Health Organization (WHO), Food and Drug Administration (FDA) work collaboratively, leading global efforts to expand health coverage. WHO keeps the nation safe through connecting its people on the health and awareness interactive platforms, and FDA promotes public health through supervision and control, defending its role in human health and services.


2021 ◽  
pp. 269-276
Author(s):  
Tahreem Kausar ◽  
Z. R. A. A. Azad ◽  
Sadaf Anwar ◽  
S. M. A. Shahid ◽  
Mohd Adnan Kausar

There is growing interest in finding healthier meals that offer more than just nutritional benefits. Meat and meat products are consumed all over the world, so it is possible to use them as matrices to make sure that people get enough bioactive components from their food. Besides extending the meat product's shelf-life and improving its composition (by integrating antioxidant molecules), it could also help people stay healthy by lowering lipid oxidative products. In this review, we look at whether developing and eating functional meat products is a viable method for improving meat composition and stability and reducing the oxidative consequences associated with the consumption of meat intake. The inclusion of plant bioactive compounds and antioxidants in meat products should protect the composition and quality of functional meat and meat products as well as the customers' health status. The key plant components with antioxidant capabilities employed in the composition of functional meat products will be discussed in this review.


2021 ◽  
pp. 248-252
Author(s):  
Mohammed Alrouji

The ponesimod oral therapy was approved in March 2021 by the United States Food and Drug Administration for relapsing forms multiple sclerosis (MS). Ponesimod is a sphingosine 1-phosphate (S1P) receptor 1 modulator that acts selectively as an anti- inflammatory agent and provides a suitable microenvironment for the function of the other neuroprotective agents. Ponesimod is contraindicated in patients who in the last 6 months, have experienced myocardial infarction, unstable angina, stroke, transient ischemic attack (TIA), decompensated heart failure requiring hospitalization, or Class III or IV heart failure. Also contraindicated in patients who have the presence of Mobitz type II second-degree, third-degree atrioventricular (AV) block, sick sinus syndrome, or sino-atrial block, unless the patient has a functioning pacemaker. This article briefs the information about dosage, precautions and warnings required in cardiovascular disease patients before initiation of ponesimod oral therapy.


2021 ◽  
pp. 261-268
Author(s):  
Aqeel Ahmad ◽  
Mohammed Ali Mullah Fawaz

Human antimicrobial peptides LL-37 have a variety of medicinal uses. It has been portrayed that this peptide has robust tumoricidal action in a range of malignancies, particularly ovarian cancer, lung cancer, breast cancer, prostate cancer, pancreatic cancer, malignant melanoma, and squamous cell carcinoma of the skin. It exhibits substantial anticancer action against a range of cancers, including colon cancer, gastric cancer, hematologic malignancy, and oral squamous cell carcinoma (OSCC), in comparison. In this review, we explored in depth the anticancer mechanism of action of LL-37 in numerous sorts of cancer. We have shown how LL-37 impedes colon cancer by eliciting caspase-independent apoptosis. LL-37, in addition, has been noticed to boost tumor-suppressive bone morphogenetic protein signaling in gastric cancer cells via restricting the proteasome, which has been previously reported. In this research, we investigated how DNA methylation interferes with the activity of the human CAMP (Cathelicidin antimicrobial peptide gene) promoter and, as a result, acts as a tumor inhibitor in mouth squamous cell carcinoma. Additionally, how LL-37 inhibits cancer cell development in hematologic malignancy has been explored through caspase-independent but Ca2+/calpain- and AIF-dependent processes.


2021 ◽  
pp. 253-260
Author(s):  
Yusuf Jamal ◽  
Fahad Al-Khodairy

The discovery of da Vinci surgical systems significantly contributed to cancer surgeries worldwide, however, the clinical and oncological outcomes are still debatable. Many retrospective studies have highlighted the advantage of robotic surgery over laparoscopic or open surgical procedures for various cancers, however, more multicentered, coordinated, random clinical trials must be conducted to outline the specific advantages of da Vinci robots. They have been widely used in cancer surgeries, however, higher operative cost and comparable oncological outcomes with laparoscopic approaches further forced manufacturers to come up with affordable and efficient specialized robotic surgery systems. Nevertheless, robotic surgery using da Vinci robots has been widely accepted for hysterectomy and prostatectomy over the laparoscopic procedure and this review briefly discusses da Vinci robots in the surgery of various human cancers and their clinical outcomes.


2021 ◽  
pp. 229-240
Author(s):  
Nidhi Sharma ◽  
Salman Akhtar ◽  
Mohammad Kalim Ahmad Khan

Bioplastics are a type of plastic which are natural and renewable. These are made from raw materials such as sugarcane, corn starch, wood, wastepaper, fats, bacteria, algae. Bioplastics are eco-friendly as they can decompose back into carbon dioxide. Reduction of greenhouse gases through reduced carbon footprint occurs by the usage of renewable resources. In contrast to petrochemical plastics, bioplastics production is around 80% which is less than carbon dioxide. Bioplastics have been used as attractive materials for biomedical applications due to their physicochemical, biological, and degradation properties. Due to the widespread use of bioplastics, they are essential materials. Biowaste products should be designed correctly for the benefit of the environment and the utilization of these products. In composting and an anaerobic digestion infrastructure, a part of biorefineries, technology is beneficial. Enhanced production of plastics across the globe has been added more waste pollution. Recycling plastic waste is one solution to the increased plastic pollution, but it alone is not the only one. Decreased usage of fossil-based plastics is vital in the aspect of sustainability. This study aims to review the recent advances of bioplastics and their possible implications for controlling and managing plastic pollution.


2021 ◽  
pp. 217-228
Author(s):  
Rukhsar Basheer ◽  
Nasreen Jahan ◽  
Jamil Ahmad

Aim of the study: To evaluate the efficacy of Majoon Muṣaffī-i-Khūn (MMK) in cyclophosphamide-induced thrombocytopenia in male Sprague Dawley rats. Material and Methods: Thrombocytopenia was induced by administration of Cyclophosphamide (25 mg/kg, 3 days, SC). Simultaneously, the animals were treated with MMK (300 and 600 mg/kg) orally and continued for three weeks. After completion of treatment, blood samples were collected by retro-orbital puncture and analyzed for WBC, RBC, Hb, and platelet counts, with bleeding and clotting time. MMK insignificantly increased the platelets, WBC, RBC, and Hb with a significant decreased in bleeding (p<0.001; p<0.05) and clotting times (P<0.01, P<0.001) which was altered by cyclophosphamide. Results: The results demonstrated that MMK improved platelet counts, clotting, and bleeding time as well as restored the altered level of WBC, RBC, and Hb. Conclusion: Based on the above results it can be concluded that the hydroalcoholic extract of MMK may have the potential to normalize the blood composition effectively.


2021 ◽  
pp. 204-216
Author(s):  
Mohd Umar Azeem ◽  
Salman Akhtar ◽  
Mohammed Haris Siddiqui ◽  
Mohammad Kalim Ahmad Khan

The general mechanism of cancer includes the metabolism of carcinogens to highly electrophilic metabolites capable of binding to DNA and other macromolecules, thereby initiating the cells. As the carcinogenesis mechanism is quite complex where diverse cellular mechanism(s) are involved in cancer promotion and progression, it is challenging to elucidate various underlying mechanisms. The intense research to study the diverse nature of cancer initiation and development with the associated risk factors and modulators has resulted in innumerable molecular and cellular markers specific to different cancer types. Almost all the exogenous compounds entering the cells are metabolized by enzymes of phase I and phase II. During biotransformation of any pro-carcinogens and other xenobiotics, the activation of phase I and suppression of phase II enzymes are required to exert their mutagenic, toxic, or carcinogenic effect. Metabolic activation, detoxification, cellular proliferation, programmed cell death, angiogenesis, and metastasis have been involved in target-specific pathways leading to oncogenic mechanisms elucidation. The interaction of parent xenobiotics with a particular target can either positively, negatively, or neutrally influence their respective cellular pathways. In the study, biotransformation by CYP450 isozymes, detoxification by GST (glutathione S-transferase) and NAT (N-acetyltransferase) isozymes, DNA adduction formation, and (dibenzo[a,l]pyrene) DBP-mediated cell proliferation have been comprehensively reviewed.


2021 ◽  
pp. 192-203
Author(s):  
Mansi Agrahari ◽  
Kanu Megha ◽  
Kajal Dahiya ◽  
Ila Sharma ◽  
Ankur Sharma ◽  
...  

Objective: In-silico methods to find and characterize the ligands against the active site of tau protein which could assist in the therapeutics of Alzheimer's disease. Methods: The aid of various bioinformatic tools such as phylogenetic analysis, homology modeling, and active site prediction led to the molecular docking analysis of the major malefactor for Alzheimer’s disease ‘microtubule- associated tau protein’. A three-dimensional structure of microtubule-related tau protein was created, and the Ramachandran plot was acquired for quality appraisal. Results: Procheck showed 62.95 of residues in the most preferred region with 20% residues in the additional allowed region and 5.7 % in the disallowed region of microtubule-associated tau protein. Screenings of the particles were done dependent on Lipinski's standard of five. Conclusion: Genistein, Hesperidin, and epigallocatechin-3 are the potential ligands in regulating microtubule-related tau protein and Epigallocatechin-3 gallate is the most potent among them and the most elevated negative free vitality of official with the maximum interacting surface territory throughout docking studies.


Sign in / Sign up

Export Citation Format

Share Document